论文部分内容阅读
目的探讨黄芪注射液辅助治疗小儿病毒性心肌炎的疗效。方法选取2011年12月—2013年12月甘孜州道孚县人民医院收治的小儿病毒性心肌炎患儿132例,根据治疗方式不同将患儿分成为常规治疗组与联合治疗组,各66例。常规治疗组予以常规治疗,联合治疗组患儿在常规治疗基础上加用黄芪注射液治疗。观察两组患儿相关症状改善情况(症状消失时间、体征消失时间、心肌酶恢复时间、心电图恢复时间)、临床疗效及不良反应发生情况。结果联合治疗组患儿症状消失时间、体征消失时间、心肌酶恢复时间、心电图恢复时间短于常规治疗组,差异有统计学意义(P<0.05);联合治疗组患儿总有效率高于常规治疗组(P<0.05);两组患者均未出现严重不良反应。结论黄芪注射液辅助治疗小儿病毒性心肌炎的临床效果显著,可改善患儿临床症状,且不良反应少。
Objective To investigate the therapeutic effect of astragalus injection on viral myocarditis in children. Methods A total of 132 children with viral myocarditis admitted to Daofu County People’s Hospital of Ganzi Prefecture from December 2011 to December 2013 were divided into routine treatment group and combination therapy group, 66 cases in each group. The conventional treatment group was given routine treatment. The combined treatment group was treated with astragalus injection on the basis of routine treatment. The improvement of the symptoms of the two groups were observed (symptom disappear time, the disappearance of signs, myocardial enzyme recovery time, ECG recovery time), clinical efficacy and adverse reactions. Results Symptom disappearance time, disappearance of signs, recovery time of myocardial enzymes and electrocardiogram in the combined treatment group were shorter than those in the conventional treatment group (P <0.05). The total effective rate in the combined treatment group was higher than that in the conventional treatment group Treatment group (P <0.05). No serious adverse reactions occurred in both groups. Conclusion Astragalus injection adjuvant treatment of children with viral myocarditis significant clinical effect, can improve clinical symptoms in children, and fewer adverse reactions.